Emergent Biosolutions IncAdd to My Watchlist

EBS:USNew YorkIndustry: Medical-Biomedical/Gene
  • 21.45
    Last
  • 0.15  -0.69%
    Today's Change
  • 21.60
    Previous Close
  • Today
     
    18.28
    28.48
    52 Week Low - High
8:04 pm ET 10/24/2014
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding37 million
Market Cap$804 million
Return on Equity ttm2.88%
Last DividendEBS:US does not pay a dividend
Earnings
EPS: Year Actual ttm0.562
EPS: Year Est. 12/14 ttm0.907
 
EPS: Quarterly Actual 6/14 0.13
EPS: Quarterly Est. 9/14 0.47
 
Price/Earnings ttm38.15
Relative Price/Earnings2.175
Earnings Growth Rate32.31
Company Description
Emergent Biosolutions, Inc. develops and produces immunobiotics, pharmaceutical products that assist the body's immune system to prevent or treat disease. The Company produces a vaccine for anthrax.
Revenue$313 million
Net Income$31 million
Total Assets$627 million
Employees1,353
Web Sitewww.emergentbiosolutions.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!